Who We Are

HaemSTAR is a UK-wide network of passionate Clinical Haematology registrars and trainees. We are supported by the National Institute for Health Research (NIHR) classical haematology Clinical Research Network (CRN).

HaemSTAR

HaemSTAR is an independent UK-wide network of registrars and trainees, interested in promoting and performing research in classical haematology. Our focus is on collaborative projects across haemostasis & thrombosis, transfusion, general haematology, and obstetric haematology.

We aim to promote research in classical haematology by:

  • Assisting outside studies: This increases patient recruitment to classical haematology trials.

  • Upscaling worthy local projects to the national scale: This increases the power and applicability of study results.

  • Providing Principle Investigator (PI) experience: This enables more haematologists in training to lead clinical research within their trusts.

  • Developing and leading our own studies: This creates chief investigators of the future.

How we operate

A small committee manages a hub-and-spoke model covering over 25 regions in the United Kingdom. Each region has a haematology registrar, acting as a regional lead, that organises research activity at a local level. We are supported by the NHT Haematology National Speciality Group, British Society for Haematology and the National Institute for Health Research (NIHR) classical haematology Clinical Research Network (CRN).

Our Funding

HaemSTAR is a registered charity (Charity Number: 1199224).

We are proud to work with a number of charitable, governmental and industry partners. We have received funding for our projects and educational events from the following sources:

  • AstraZeneca

  • Chugai Pharma UK

  • Dudley Leukaemia Unit Appeal Fund

  • Novartis

  • Octapharma

  • Sanofi

  • Scientific and Academic Coagulation Consortium (Katie Bolam Award)

  • West Midlands NIHR LCRN

  • SOBI- Swedish Orphan Biovitrum AB

Authorship Policy

All publications that arise from HaemSTAR projects are authored on behalf of the group. As collaborators are involved at every stage of the project (design, execution and dissemination), we ask journals to provide all contributors with PubMed citable authorship. This is in line with the International Committee of Medical Journal Editors guidelines. An example can be found here.

In March 2022 we introduced a HaemSTAR Agreement of Authorship, which will be required of any project that involves significant input from the HaemSTAR network. We are happy to work with study leads to identify journals that have a record of delivering citable collaborative authorship.